Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
British Journal of Dermatology2019Vol. 181(2), pp. 256–264
Citations Over TimeTop 24% of 2019 papers
K.J. Mason, S. Williams, Zenas Z N Yiu, Kathleen McElhone, Darren M. Ashcroft, C. Elise Kleyn, Zarif K. Jabbar‐Lopez, Caroline Owen, Nick J. Reynolds, Catherine Smith, Nina Wilson, Richard B. Warren, C.E.M. Griffiths
Abstract
The comparative persistence and effectiveness of acitretin, ciclosporin, FAE and methotrexate in real-world clinical practice in the past decade cannot be well described due to the inconsistency of the methods used.
Related Papers
- → Pharmacokinetics and drug interactions of etretinate and acitretin(1992)20 cited
- → Trans -Acitretin wird in Etretinat rückmetabolisiert(1996)9 cited
- Acitretin, a systemic retinoid for the treatment of psoriasis - current state of knowledge(2011)
- Pharmacokinetics of acitretin.(1994)
- [Acitretin therapy in keratinization disorders].(1990)